Search results
Results from the WOW.Com Content Network
Rituximab: 375 mg/m 2: IV infusion: Day 1 Etoposide: 50 mg/m 2: IV continuous infusion over 24 h: Days 1–4 Prednisolone: 60 mg/m 2: By mouth, twice a day (PO BID) Days 1–5 Oncovin: vincristine: 0.4 mg/m 2: IV continuous infusion over 24 h: Days 1–4 Cyclophosphamide: 750 mg/m 2: IV bolus given over 15 min: Day 5 Hydroxydaunorubicin ...
Rituximab, sold under the brand name Rituxan among others, is a monoclonal antibody medication used to treat certain autoimmune diseases and types of cancer. [18] It is used for non-Hodgkin lymphoma, chronic lymphocytic leukemia (in children and adults, but not recommended in elderly patients), rheumatoid arthritis, granulomatosis with polyangiitis, idiopathic thrombocytopenic purpura ...
Rituximab: 375 mg/m 2: IV infusion: Day 0 Etoposide: 40 mg/m 2: IV infusion over 1 hr: Days 1-4 Solu-Medrol - Methylprednisolone: 500 mg: IV bolus over 15 min: Days 1-5 High-dose Ara-C — cytarabine: 2000 mg/m 2: IV infusion over 2 hrs: Day 5 Platinol (cisplatin) 25 mg/m 2: IV continuous infusion over 24 hrs: Days 1-4
Medicare Part B (medical insurance) may cover Rituxan (rituximab) infusions. This is because medical professionals typically administer the medication in a medical setting on an outpatient basis.
Rituximab: 375 mg/m 2: IV infusion: Day 1 Mesna: 1330 mg/m 2: IV infusion over 1h together with ifosfamide, plus 500 mg PO 4h after ifosfamide: Days 1-3 Ifosfamide: 1330 mg/m 2: IV infusion over 1h: Days 1-3 Mitoxantrone: 8 mg/m 2: IV infusion: Day 1 Etoposide: 65 mg/m 2: IV infusion over 1h: Days 1-3
In combination with rituximab it is called R-FM or RFM or FM-R or FMR. ... 375 mg/m 2: IV infusion: Day 1 ludarabine: 25 mg/m 2: IV infusion: Days 1-3 itoxantrone:
In 2009 Levy was awarded the King Faisal International Prize in Medicine, sometimes called the "Arab Nobel Prize".He was awarded the prize for his work on Rituxan. In an interview with Haaretz, Levy said that he was very surprised when he was notified by the prize committee about his victory.
Cancer slope factors (CSF) are used to estimate the risk of cancer associated with exposure to a carcinogenic or potentially carcinogenic substance. A slope factor is an upper bound, approximating a 95% confidence limit, on the increased cancer risk from a lifetime exposure to an agent by ingestion or inhalation.